series	seriesDescription	geoAreaCode	geoAreaName	timePeriodStart	value	valueType	time_detail	timeCoverage	upperBound	lowerBound	basePeriod	source	geoInfoUrl	footnotes	Nature	Units	Reporting Type
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	498	Republic of Moldova	2013.0	1	Float						WHO/UNICEF coverage estimates 2018 revision, July 2019		['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	498	Republic of Moldova	2014.0	28	Float						WHO/UNICEF coverage estimates 2018 revision, July 2019		['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	498	Republic of Moldova	2015.0	71	Float						WHO/UNICEF coverage estimates 2018 revision, July 2019		['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	498	Republic of Moldova	2016.0	77	Float						WHO/UNICEF coverage estimates 2018 revision, July 2019		['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	498	Republic of Moldova	2017.0	78	Float						WHO/UNICEF coverage estimates 2018 revision, July 2019		['']	E	PERCENT	G
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	498	Republic of Moldova	2018.0	94	Float						WHO/UNICEF coverage estimates 2018 revision, July 2019		['']	E	PERCENT	G
